Markets:

Overview

News

Currencies

International

Treasuries

MEDIFAST INC Common Stock (NY:MED)

12.35 +2.61 (+26.80%)

Streaming Delayed Price Updated: 9:54 AM EDT, Aug 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about MEDIFAST INC Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Medifast Q2 Earnings Call Highlights ↗

August 03, 2026

Medifast (NYSE:MED) reported second-quarter 2026 revenue of $76.4 million, down 27.6% from a year earlier, as its active earning coach base continued to decline amid the rapid adoption of GLP-1...

Via MarketBeat

Topics Earnings

Medifast (NYSE:MED) Beats Expectations in Strong Q2 CY2026, Stock Jumps 12.8%

August 03, 2026

Wellness company Medifast (NYSE:MED) reported Q2 CY2026 results topping the market’s revenue expectations, but sales fell by 27.6% year on year to $76.38 mil...

Via StockStory

Topics Artificial Intelligence

11 Consumer Staples Stocks Moving In Monday's After-Market Session ↗

August 03, 2026

Gainers Medifast (NYSE:MED) stock increased by 10.7% to $10.78 during Monday's after-market session. The market value of their outstanding shares is at $108.0 million. The company's, Q2 earnings came...

Via Benzinga

Earnings To Watch: Medifast (MED) Reports Q2 Results Tomorrow

August 01, 2026

Wellness company Medifast (NYSE:MED) will be reporting results this Monday after market hours. Here’s what you need to know. Medifast beat analysts’ revenue ...

Via StockStory

Medifast (NYSE:MED) Q1 Loss Narrower Than Feared as Coach Productivity Improves ↗

May 04, 2026

Via Chartmill

Medifast Inc (NYSE:MED) Reports Mixed Q4 Results with Deepening Losses and Challenging 2026 Outlook ↗

February 17, 2026

Via Chartmill

3 Out-of-Favor Stocks with Questionable Fundamentals

July 27, 2026

The past year hasn’t been kind to the stocks featured in this article. Each has tumbled to its lowest point in 12 months, leaving investors to decide whether...

Via StockStory

3 Unpopular Stocks That Concern Us

July 16, 2026

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...

Via StockStory

Topics Artificial Intelligence

A Look Back at Personal Care Stocks’ Q1 Earnings: Medifast (NYSE:MED) Vs The Rest Of The Pack

July 13, 2026

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...

Via StockStory

Topics Economy

1 Cash-Heavy Stock to Target This Week and 2 Facing Headwinds

July 10, 2026

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face c...

Via StockStory

3 Reasons MED is Risky and 1 Stock to Buy Instead

July 07, 2026

Since January 2026, Medifast has been in a holding pattern, posting a small return of 3.3% while floating around $11.05. Is now the time to buy Medifast, or ...

Via StockStory

Medifast (MED) Q1 2026 Earnings Transcript ↗

May 04, 2026

Medifast (MED) Q1 2026 Earnings Transcript

Via The Motley Fool

Medifast (NYSE:MED) Delivers Impressive Q1 CY2026

May 04, 2026

Wellness company Medifast (NYSE:MED) reported Q1 CY2026 results exceeding the market’s revenue expectations, but sales fell by 34.3% year on year to $76.04 m...

Via StockStory

Medifast (MED) Q1 Earnings: What To Expect

May 02, 2026

Wellness company Medifast (NYSE:MED) will be reporting earnings this Monday afternoon. Here’s what to expect. Medifast beat analysts’ revenue expectations la...

Via StockStory

Topics Artificial Intelligence

3 Unprofitable Stocks Walking a Fine Line

April 21, 2026

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. Finding...

Via StockStory

Personal Care Stocks Q4 In Review: Coty (NYSE:COTY) Vs Peers

April 06, 2026

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including Coty (NYSE:COTY) and its pe...

Via StockStory

Topics Economy

3 Consumer Stocks That Concern Us

April 06, 2026

Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. Surprisingly, the sector hasn’t played its shielding role over t...

Via StockStory

3 of Wall Street’s Favorite Stocks We Steer Clear Of

April 02, 2026

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...

Via StockStory

3 Reasons MED is Risky and 1 Stock to Buy Instead

March 30, 2026

What a brutal six months it’s been for Medifast. The stock has dropped 27.7% and now trades at $9.88, rattling many shareholders. This was partly driven by i...

Via StockStory

Topics Artificial Intelligence

1 Small-Cap Stock with Exciting Potential and 2 We Find Risky

March 27, 2026

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...

Via StockStory

Winners And Losers Of Q4: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks

March 22, 2026

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the personal care stocks, including Medifast (NYSE:MED) and its peers. While personal c...

Via StockStory

Topics Economy

3 Out-of-Favor Stocks with Open Questions

March 10, 2026

The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet...

Via StockStory

Medifast’s Q4 Earnings Call: Our Top 5 Analyst Questions

February 24, 2026

Medifast’s fourth quarter results outperformed Wall Street’s revenue expectations, which the market responded to positively. Management attributed this to early signs of success from its transition to...

Via StockStory

Topics Earnings

MED Q4 Deep Dive: Metabolic Health Pivot Drives Early Coach Productivity Gains

February 18, 2026

Wellness company Medifast (NYSE:MED) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales fell by 36.9% year on year to $75.1 million. On the other hand, next quarter’s revenue...

Via StockStory

Medifast (MED) Q4 2025 Earnings Call Transcript ↗

February 17, 2026

Medifast (MED) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Medifast’s (NYSE:MED) Q4 CY2025 Sales Top Estimates

February 17, 2026

Wellness company Medifast (NYSE:MED) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 36.9% year on year to $75.1 million. On the other hand, next quarter’s...

Via StockStory

Earnings To Watch: Medifast (MED) Reports Q4 Results Tomorrow

February 15, 2026

Wellness company Medifast (NYSE:MED) will be reporting results this Tuesday after the bell. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

3 Stocks Under $50 We Approach with Caution

February 01, 2026

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and...

Via StockStory

1 of Wall Street’s Favorite Stock to Target This Week and 2 We Question

January 29, 2026

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

3 Russell 2000 Stocks We’re Skeptical Of

January 20, 2026

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.